Clinical Trials

Sponsor: NRG

Sponsor Study ID: BR007

Study Title: A Phase III Clinical Trial Evaluating De-Escalation of Breast Radiation for Conservative Treatment of Stage I, Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer

NCT Number: NCT04852887

Phase: III

Protocol Type: Treatment

Age Group: Adult

Disease Sites: Breast

Study Objectives: This Phase III Trial evaluates whether breast conservation surgery and endocrine therapy results in a non-inferior rate of invasive or non-invasive ipsilateral breast tumor recurrence (IBTR) compared to breast conservation with breast radiation and endocrine therapy.

If you would like to contact a MUSC study team member to learn more information about this study, click HERE.